Anxo Pharmaceutical Co., Ltd. (TPEX:6677)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.00
+0.70 (3.63%)
Apr 29, 2026, 1:45 PM CST
11.42%
Market Cap 1.13B
Revenue (ttm) 883.22M
Net Income (ttm) -42.34M
Shares Out 55.87M
EPS (ttm) -0.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 266,518
Average Volume 112,410
Open 19.30
Previous Close 19.30
Day's Range 19.30 - 20.10
52-Week Range 15.75 - 30.50
Beta 0.39
RSI 55.06
Earnings Date Apr 30, 2026

About Anxo Pharmaceutical

Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. The company offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. It also offers drugs for antidiabetic/dyslipidaemic agents, cardiovascular/circulatory system, nervous system, hepatology/gastroentero... [Read more]

Sector Healthcare
Founded 2003
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6677
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.